EVA1A and liver cancer: It has been found that EVA1A is significantly downregulated in human tumor tissues such as liver cancer, esophageal squamous cell carcinoma, gastric adenocarcinoma and pancreatic tumors [9, 10, 34], indicating that it may be involved in the occurrence or development of these tumors.